<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Emerging Roles of Nanocarrier in Cancer Therapy</title>
  </titleInfo>
  <name type="personal">
    <namePart>Malviya, Rishabha</namePart>
    <affiliation>Galgotias Uni.</affiliation>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Singh, Arun Kumar</namePart>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Sundram, Sonali</namePart>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">flu</placeTerm>
    </place>
    <dateIssued encoding="marc">2025</dateIssued>
    <edition>First edition.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <extent>1 online resource (xiv, 180 pages).</extent>
  </physicalDescription>
  <abstract>This book addresses the limitations of existing therapeutic approaches using nanoparticles. Emerging Roles of Nanocarriers in Cancer Therapy will further provide information for the development of successful cancer nanomedicine therapies. Features Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment. Covers in detail the characteristics of various nanotechnology-based drug delivery systems. Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction. Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research. Highlights smart strategies for improving the clinical impact of cancer nanomedicine. The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology.</abstract>
  <tableOfContents>Chapter 1: Nanomedicine as Cancer Therapeutics: Current Trends and OpportunitiesChapter 2: Technology Utilizing Nanoparticles in Treating CancerChapter 3: Targeted Therapy for Cancer with NanomedicineChapter 4: Effective Nanomedicine for cancer TherapyChapter 5: Enhancing Cancer Immunotherapy using Nanoparticle-Based Smart CarriersChapter 6: Opportunities and Challenges for Anticancer Nanomedicines based on Polymer-Drug Conjugates in Concurrent /combination treatmentChapter 7: siRNA Therapeutic Nanocarriers for the Treatment of CancerChapter 8: Boosting Nano Medicine Efficacy with Hyperbaric Oxygen TherapyChapter 9: Combo Nanomedicine: The Co-delivery of Multimodal Therapies for Effective, Targeted Plus Secure Treatment of CancerChapter 10: Multipurpose Micellar Nanomedicine for the Treatment of CancerChapter 11: Cellular Targeting using Nanoparticles for Targeted Cancer TherapyIndex</tableOfContents>
  <targetAudience authority="marctarget">general</targetAudience>
  <note type="statement of responsibility">Rishabha Maviya, Arun Kumar Singh, and Sonali Sundram.</note>
  <subject authority="lcsh">
    <topic>Cancer</topic>
    <topic>Treatment</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL / Chemotherapy</topic>
  </subject>
  <classification authority="lcc">RC270.8</classification>
  <identifier type="isbn">9781003451020</identifier>
  <identifier type="isbn">1003451020</identifier>
  <identifier type="isbn">9781040105986</identifier>
  <identifier type="isbn">104010598X</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn">9781040105993</identifier>
  <identifier type="isbn">1040105998</identifier>
  <identifier type="uri">https://www.taylorfrancis.com/books/9781003451020</identifier>
  <identifier type="uri">http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf</identifier>
  <location>
    <url displayLabel="Taylor &amp; Francis">https://www.taylorfrancis.com/books/9781003451020</url>
  </location>
  <location>
    <url displayLabel="OCLC metadata license agreement">http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">OCoLC-P</recordContentSource>
    <recordCreationDate encoding="marc">240715</recordCreationDate>
    <recordChangeDate encoding="iso8601">20251030122249.0</recordChangeDate>
    <recordIdentifier source="FlBoTFG">9781003451020</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
